EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

The potential role of tranexamic acid and botulinum toxin in treating patients with acne vulgaris: a split face comparative study

Mohamed Metwalli, Amina Ali Mohamed, Reham Essam

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04127-9 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Mohamed Metwalli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Acne Vulgaris, Tranexamic Acid, Botulinum Toxins, Type A. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Many causes can lead to acne, such as increased sebum production, altered sebum lipid quality from increased androgen activity, abnormal keratinization of the infundibular epithelium, and Propionibacterium acnes (P. acnes) colonizing the follicles. AIM: The present study aimed to evaluate and compare the clinical efficacy of botulinum toxin-A vs. tranexamic acid intradermal injection in the treatment of acne vulgaris. METHODS: This split face study includes forty patients with varying grades of acne vulgaris. They were injected intradermally with tranexamic acid (20 mg/ml) on the left side for three sessions two weeks apart and once with botulinum toxin-A on the right side. RESULTS: After treatment, the Total Lesion Count, Comprehensive Acne severity Scale, and Clinical Erythema Assessment Scale significantly reduced, with a greater reduction in erythema on the tranexamic acid side and a greater reduction of comedones on the botulinum toxin side. CONCLUSION: Tranexamic acid and botulinum toxin-A can be promising adjuvants in treating acne vulgaris by their specific mechanisms in the dermatological domain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisTranexamic AcidBotulinum Toxins, Type AHumansFemaleMaleAdultYoung AdultTreatment OutcomeInjections, IntradermalAdolescentSeverity of Illness IndexPropionibacterium acnes

Stichwörter der Autor:innen

Acne vulgarisBotulinum toxinIntradermal therapyTranxamic acid

Substanzen

Tranexamic AcidBotulinum Toxins, Type A

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. rereessam22@gmail.com.

Zitieren

APA

Metwalli, M., Mohamed, A. A., & Essam, R. (2025). The potential role of tranexamic acid and botulinum toxin in treating patients with acne vulgaris: a split face comparative study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04127-9

Vancouver

Metwalli M, Mohamed AA, Essam R. The potential role of tranexamic acid and botulinum toxin in treating patients with acne vulgaris: a split face comparative study. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04127-9

BibTeX
@article{Metwalli2025,
  author = {Metwalli, Mohamed and Mohamed, Amina Ali and Essam, Reham},
  title = {The potential role of tranexamic acid and botulinum toxin in treating patients with acne vulgaris: a split face comparative study},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04127-9}
}
Kostenlos starten →